These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 34309766

  • 21. Assessment of naive indolent lymphoma using whole-body diffusion-weighted imaging and T2-weighted MRI: results of a prospective study in 30 patients.
    Hong GS, Chae EJ, Ryu JS, Chae SY, Lee HS, Yoon DH, Suh C.
    Cancer Imaging; 2021 Jan 07; 21(1):5. PubMed ID: 33413685
    [Abstract] [Full Text] [Related]

  • 22. Artifact-robust diffusion-weighted whole-body imaging with background suppression at 3 T using improved turbo spin-echo diffusion-weighted imaging.
    Suzuki M, Morita S, Goto Y, Tadenuma H, Nishina Y, Yoneyama M, Tanaka I, Sakai S.
    Br J Radiol; 2019 Feb 07; 92(1094):20180489. PubMed ID: 30407840
    [Abstract] [Full Text] [Related]

  • 23. Inter-observer agreement of baseline whole body MRI in multiple myeloma.
    Croft J, Riddell A, Koh DM, Downey K, Blackledge M, Usher M, Boyd K, Kaiser M, Messiou C.
    Cancer Imaging; 2020 Jul 14; 20(1):48. PubMed ID: 32665028
    [Abstract] [Full Text] [Related]

  • 24. Inter-observer agreement for the evaluation of bone involvement on Whole Body Low Dose Computed Tomography (WBLDCT) in Multiple Myeloma (MM).
    Zacchino M, Bonaffini PA, Corso A, Minetti V, Nasatti A, Tinelli C, Dore R, Calliada F, Sironi S.
    Eur Radiol; 2015 Nov 14; 25(11):3382-9. PubMed ID: 25987427
    [Abstract] [Full Text] [Related]

  • 25. Diagnostic accuracy and agreement between whole-body diffusion MRI and bone scintigraphy in detecting bone metastases.
    Stecco A, Lombardi M, Leva L, Brambilla M, Negru E, Delli Passeri S, Carriero A.
    Radiol Med; 2013 Apr 14; 118(3):465-75. PubMed ID: 22872462
    [Abstract] [Full Text] [Related]

  • 26. Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?
    Pawlyn C, Fowkes L, Otero S, Jones JR, Boyd KD, Davies FE, Morgan GJ, Collins DJ, Sharma B, Riddell A, Kaiser MF, Messiou C.
    Leukemia; 2016 Jun 14; 30(6):1446-8. PubMed ID: 26648535
    [No Abstract] [Full Text] [Related]

  • 27. [Contribution of whole-body magnetic resonance in the diagnostics of monoclonal gammopathy of undetermined significance, multiple myeloma, and the assessment of Durie-Salmon Plus staging system].
    Scudla V, Herman M, Minarík J, Pika T, Hrbek J, Bacovský J, Heinzová V.
    Vnitr Lek; 2011 Jan 14; 57(1):52-60. PubMed ID: 21351663
    [Abstract] [Full Text] [Related]

  • 28. Whole-body diffusion-weighted magnetic resonance imaging in the staging of oncological patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study.
    Stecco A, Romano G, Negru M, Volpe D, Saponaro A, Costantino S, Sacchetti G, Inglese E, Alabiso O, Carriero A.
    Radiol Med; 2009 Feb 14; 114(1):1-17. PubMed ID: 19082787
    [Abstract] [Full Text] [Related]

  • 29. Fused high b-value diffusion weighted and T2-weighted MR images in staging of pediatric Hodgkin's lymphoma: A pilot study.
    Spijkers S, Nievelstein RAJ, de Keizer B, Bruin MCA, Littooij AS.
    Eur J Radiol; 2019 Dec 14; 121():108737. PubMed ID: 31734638
    [Abstract] [Full Text] [Related]

  • 30. Whole-body MRI versus an FDG-PET/CT-based reference standard for staging of paediatric Hodgkin lymphoma: a prospective multicentre study.
    Spijkers S, Littooij AS, Kwee TC, Tolboom N, Beishuizen A, Bruin MCA, Elias SG, van de Brug T, Enríquez G, Sábado C, Miller E, Granata C, de Lange C, Verzegnassi F, Greer MC, de Keizer B, Nievelstein RAJ.
    Eur Radiol; 2021 Mar 14; 31(3):1494-1504. PubMed ID: 32880696
    [Abstract] [Full Text] [Related]

  • 31. Pictorial review of whole body MRI in myeloma: emphasis on diffusion-weighted imaging.
    Hameed M, Sandhu A, Soneji N, Amiras D, Rockall A, Messiou C, Wallitt K, Barwick TD.
    Br J Radiol; 2020 Nov 01; 93(1115):20200312. PubMed ID: 32667830
    [Abstract] [Full Text] [Related]

  • 32. Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences.
    Larbi A, Omoumi P, Pasoglou V, Michoux N, Triqueneaux P, Tombal B, Cyteval C, Lecouvet FE.
    Eur Radiol; 2019 Aug 01; 29(8):4503-4513. PubMed ID: 30413957
    [Abstract] [Full Text] [Related]

  • 33. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?
    Baur A, Stäbler A, Nagel D, Lamerz R, Bartl R, Hiller E, Wendtner C, Bachner F, Reiser M.
    Cancer; 2002 Sep 15; 95(6):1334-45. PubMed ID: 12216103
    [Abstract] [Full Text] [Related]

  • 34. Multi-parametric (mp) MRI for the diagnosis of abdominal wall desmoid tumors.
    Khanna M, Ramanathan S, Kambal AS, Al-Berawi M, Yadav S, Kumar D, Schieda N.
    Eur J Radiol; 2017 Jul 15; 92():103-110. PubMed ID: 28624006
    [Abstract] [Full Text] [Related]

  • 35. Comparison of PET-CT and magnetic resonance diffusion weighted imaging with body suppression (DWIBS) for initial staging of malignant lymphomas.
    Stéphane V, Samuel B, Vincent D, Joelle G, Remy P, Francois GG, Jean-Pierre T.
    Eur J Radiol; 2013 Nov 15; 82(11):2011-7. PubMed ID: 23932096
    [Abstract] [Full Text] [Related]

  • 36. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
    Noij DP, Boerhout EJ, Pieters-van den Bos IC, Comans EF, Oprea-Lager D, Reinhard R, Hoekstra OS, de Bree R, de Graaf P, Castelijns JA.
    Eur J Radiol; 2014 Jul 15; 83(7):1144-1151. PubMed ID: 24768188
    [Abstract] [Full Text] [Related]

  • 37. Diagnostic performance of 18F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma.
    Ishiguchi H, Ito S, Kato K, Sakurai Y, Kawai H, Fujita N, Abe S, Narita A, Nishio N, Muramatsu H, Takahashi Y, Naganawa S.
    Ann Nucl Med; 2018 Jun 15; 32(5):348-362. PubMed ID: 29667143
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.